ArrowArtboardCreated with Sketch.Title ChevronCrossEye IconIcon FacebookIcon LinkedinShapeCreated with Sketch.Icon Mail ContactPath LayerIcon MailMenu BurgerIcon Opinion QuotePositive ArrowIcon PrintIcon SearchSite TitleTitle ChevronIcon Twitter

Cosmetic and training-device maker MTG surges in Tokyo market debut

Shares of startup known for its Sixpad gear jump over 30% at IPO

One of MTG's most successful brands is Sixpad abdominal muscle-training gear, developed with soccer star Cristiano Ronaldo. 

TOKYO -- Japanese health and cosmetic device developer MTG went public on the Tokyo Stock Exchange on Tuesday, with investors cheering the debut in what has been described as one of Japan's few unicorns.

MTG's stock rose as high as 7,580 yen during the morning session, 31% above its initial public offering price of 5,800 yen after opening up 22%.

Founded in 1996, MTG designs and sells private-brand products in collaboration with universities, medical institutions and celebrities. One of its most successful brands is Sixpad, developed in partnership with Portuguese soccer star Cristiano Ronaldo. The brand’s abdominal muscle-training gear has sold more than 1 million units.

MTG also has the skincare brand MDNA SKIN with U.S. pop star Madonna. Its facial beauty roller device, ReFa, has sold more than 7 million units.

Although MTG’s debut was well-received, it did not make as strong an impression as Mercari, another Japanese unicorn that went public in June. The buy-and-sell app operator opened 67% above its IPO price on June 19 and rose to double the IPO price that same day.

You have {{numberReadArticles}} FREE ARTICLE{{numberReadArticles-plural}} left this month

Subscribe to get unlimited access to all articles.

Get unlimited access
NAR site on phone, device, tablet

{{sentenceStarter}} {{numberReadArticles}} free article{{numberReadArticles-plural}} this month

Stay ahead with our exclusives on Asia; the most dynamic market in the world.

Benefit from in-depth journalism from trusted experts within Asia itself.

Try 3 months for $9

Offer ends September 30th

Your trial period has expired

You need a subscription to...

See all offers and subscribe

Your full access to the Nikkei Asian Review has expired

You need a subscription to:

See all offers
NAR on print phone, device, and tablet media